← All indications
Vaginosis, Bacterial
Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.
Drugs by status
Approved for this indication (5)
Phase 4 trials (23)
- acetylcysteine
- urea
- ethinyl estradiol
- whey protein
- desogestrel
- boric acid
- noristerat
- lidocaine
- ceftriaxone
- autologous microbiome
- azithromycin
- glycogen
- chickpea
- lactic acid
- promestriene
- chlorquinaldol
- tioconazole
- hyaluronidase (bovine)
- estrogen
- Lactobacillus acidophilus
- clotrimazole
- lactobacillus reuteri
- lactobacillus rhamnosus
Phase 3 trials (19)
Phase 2 trials (10)
Phase 1 trials (8)
Organizations
Organization Involved with Phase 4 Indications (44)
- Lupin
- Merck
- Merck Serono
- Merck KGaA
- Pfizer
- Sanofi
- Sanofi-Aventis
- Allergan
- Guangzhou Yipinhong Pharmaceutical CO.,LTD
- Laboratorios Ordesa
- Shaanxi Buchang Pharmaceutical Co., Ltd
- National Institutes of Health (NIH)
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (NIAID)
- University of Pittsburgh
- BGI Group
- University of London
- Eastern Virginia Medical School
- University of Washington
- Jawaharlal Nehru Medical College
- Minia University
- Ohio State University
- Skaraborg Hospital
- Thomas Jefferson University
- University of Liverpool
- University of Bern
- Fudan University
- Peking University
- Jiao Tong University
- Ginemed Sevilla
- +14 more
Organization Involved with Phase 3 Indications (31)
- Actavis
- Mission Pharmacal
- Medicis
- Amvac Kft.
- Avva Rus, JSC
- Biose
- Danone Research
- Embil Pharmaceutical Co. Ltd
- Marjan Industria e Comercio ltda
- Capstone Therapeutics
- Medinova AG
- Starpharma Pty Ltd
- Zodiac Produtos Farmaceuticos S.A.
- National Institute for Medical Research, Tanzania
- Health Decisions
- Johns Hopkins University
- University of New Mexico
- Wayne State University
- University of British Columbia
- National Institute for Medical Research, Mwanza Research Centre
- Watson Pharmaceuticals
- Sekou-Toure Regional Hospital
- Kirov State Medical Academy
- University of Sherbrooke
- Erasmus University Rotterdam
- University of Western Ontario
- Canadian International Development Agency
- Government of Brazil
- Kirov Regional clinical Center of Perinatology
- Oswaldo Cruz Foundation
- +1 more
Organization Involved with Phase 2 Indications (15)
- CDA Research Group, Inc.
- Graceway
- Osel, Inc.
- Parexel
- Teva
- Harvard University
- Temple University
- Kaiser Permanente
- University of Toronto
- Zagazig University
- University of California, San Francisco
- Icahn School of Medicine at Mount Sinai
- Alfa Wassermann
- Centers for Disease Control and Prevention (CDC)
- Haudongchun Co., Ltd.
Organization Involved with Phase 1 Indications (8)
Organization Involved with Other Experimental Indications (20)
- CONRAD
- IBSS Biomed S.A.
- GenMont Biotech Incorporation
- Dartmouth University
- Indiana University
- Stanford University
- University of Kiel
- University of South Carolina
- University of Copenhagen
- Medical University of South Carolina
- Kuo General Hospital
- Emek Medical Center
- Hebrew University
- Hospitalsenhed Midt
- Dairyfem R&D GmbH
- University of Natural Resources and Life Sciences
- Rinda Ubuzima, Rwanda
- Weizmann Institute of Science
- Vesale Pharma
- Nnamdi Azikiwe University